Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators

被引：0
|
作者：
Samuel Frank
机构：
来源：
BMC Neurology | / 9卷
关键词：
Huntington Disease; Tetrabenazine; Open Label Extension Study; Vesicular Monoamine Transporter; Hamilton Depression Scale;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 39 条
  • [1] Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
    Frank, Samuel
    BMC NEUROLOGY, 2009, 9
  • [2] Erratum to:Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study
    Samuel Frank
    BMC Neurology, 11
  • [3] An open label study of tetrabenazine as anti-Chorea therapy in Huntington disease
    Frank, Samuel A.
    NEUROLOGY, 2007, 68 (12) : A365 - A365
  • [4] Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study (vol 9, pg 62, 2009)
    Frank, Samuel
    BMC NEUROLOGY, 2011, 11
  • [5] The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
    Samuel Frank
    Claudia Testa
    Mary C. Edmondson
    Jody Goldstein
    Elise Kayson
    Blair R. Leavitt
    David Oakes
    Christine O’Neill
    Christina Vaughan
    Jacquelyn Whaley
    Nicholas Gross
    Mark Forrest Gordon
    Juha-Matti Savola
    CNS Drugs, 2022, 36 : 1207 - 1216
  • [6] The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
    Frank, Samuel
    Testa, Claudia
    Edmondson, Mary C.
    Goldstein, Jody
    Kayson, Elise
    Leavitt, Blair R.
    Oakes, David
    O'Neill, Christine
    Vaughan, Christina
    Whaley, Jacquelyn
    Gross, Nicholas
    Gordon, Mark Forrest
    Savola, Juha-Matti
    CNS DRUGS, 2022, 36 (11) : 1207 - 1216
  • [7] Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease
    Zesiewicz, Theresa A.
    Sullivan, Kelly L.
    Hauser, Robert A.
    Sanchez-Ramos, Juan
    MOVEMENT DISORDERS, 2006, 21 (11) : 1998 - 2001
  • [8] COST EFFECTIVENESS STUDY OF TETRABENAZINE THERAPY OF CHOREA ASSOCIATED WITH HUNTINGTON'S DISEASE
    Sanchez, G.
    Gay, J. G.
    Elizondo, M.
    Heredia, I
    Pozo, L.
    VALUE IN HEALTH, 2014, 17 (03) : A61 - A61
  • [9] Long-Term Efficacy and Safety of Deutetrabenazine for Chorea in Huntington's Disease: Results From the ARC-HD Open-Label Study
    Frank, Samuel
    Testa, Claudia M.
    Stamler, David
    Kayson, Elise
    Oakes, David
    Vaughan, Christina
    Goldstein, Jody
    Whaley, Jacquelyn
    Davis, Matthew D.
    Gordon, Mark Forrest
    Savolay, Juha-Matti
    NEUROTHERAPEUTICS, 2020, 17 (SUPPL 1) : 27 - 28
  • [10] Clinical Assessment of the Effect of Tetrabenazine on Functional Scales in Huntington Disease: A Pilot Open Label Study
    Fekete, Robert
    Davidson, Anthony
    Jankovic, Joseph
    TREMOR AND OTHER HYPERKINETIC MOVEMENTS, 2012, 2
1234